Starlight Cardiovascular

Starlight Cardiovascular
Starlight Cardiovascular is developing much needed tools and devices to treat pediatric Congenital Heart Defects (CHDs). Approximately 1.3 million babies are born each year with a CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.
Location: United States, California, San Diego
Member count: 1-10
Total raised: $9.48M

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
05.10.2022Series A$

Mentions in press and media 4

05.10.2022Starlight ...---connect.or...
05.10.2022Starlight ...Starlight Cardiovascular is
10.12.2021Prestigiou...Washington D.C., Dec. 10, 2021...--marketscre...
-Starlight ...“Starlight Cardiovascular”--fastfounde...